tiprankstipranks
Actinium Pharmaceuticals price target raised to $30 from $20 at Maxim
PremiumThe FlyActinium Pharmaceuticals price target raised to $30 from $20 at Maxim
1M ago
Actinium positioned for takeout after Fusion deal, says H.C. Wainwright
PremiumThe Fly
Actinium positioned for takeout after Fusion deal, says H.C. Wainwright
1M ago
Actinium Pharmaceuticals launches Actinium-225 focused strategic initative
PremiumThe Fly
Actinium Pharmaceuticals launches Actinium-225 focused strategic initative
1M ago
Actinium announces Iomab-B achieved primary endpoint in SIERRA trial
PremiumThe FlyActinium announces Iomab-B achieved primary endpoint in SIERRA trial
4M ago
Actinium Pharmaceuticals price target lowered by $4 at B. Riley, here’s why
PremiumThe Fly
Actinium Pharmaceuticals price target lowered by $4 at B. Riley, here’s why
4M ago
Actinium to present four presentations at ASH on lomab-B, Actimab-A
PremiumThe Fly
Actinium to present four presentations at ASH on lomab-B, Actimab-A
4M ago
Cantor Fitzgerald biotech analysts to hold an analyst/industry conference call
PremiumThe FlyCantor Fitzgerald biotech analysts to hold an analyst/industry conference call
6M ago
H.C. Wainwright sees Actinium Pharmaceuticals as prime candidate for acquisition
PremiumThe Fly
H.C. Wainwright sees Actinium Pharmaceuticals as prime candidate for acquisition
7M ago
Eli Lilly deal for Point puts radiopharma names in spotlight
PremiumThe Fly
Eli Lilly deal for Point puts radiopharma names in spotlight
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100